Clinical Trial Update: An Adaptive Design Study of MTX228 [Phase 2]

View source ↗

Summary

A Phase 2 adaptive-design clinical trial of MTX228 is currently recruiting participants with Type 1 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• MTX228

Snippet

Sponsor: University of Alberta | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: RECRUITING